As of 2025-04-20, the Relative Valuation of Pulmonx Corp (LUNG) is (27.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.52 USD, the upside of Pulmonx Corp based on Relative Valuation is -715.3%.
The range of the Relative Valuation is (24.94) - (31.36) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 27.4x | 22.2x |
| Forward P/E multiples | 15.7x - 22.4x | 17.5x |
| Fair Price | (24.94) - (31.36) | (27.81) |
| Upside | -651.8% - -793.7% | -715.3% |
| Date | P/E |
| 2025-04-17 | -3.23 |
| 2025-04-16 | -3.42 |
| 2025-04-15 | -3.51 |
| 2025-04-14 | -3.86 |
| 2025-04-11 | -3.75 |
| 2025-04-10 | -3.72 |
| 2025-04-09 | -3.88 |
| 2025-04-08 | -4.08 |
| 2025-04-07 | -4.71 |
| 2025-04-04 | -4.82 |
| 2025-04-03 | -4.82 |
| 2025-04-02 | -4.87 |
| 2025-04-01 | -4.90 |
| 2025-03-31 | -4.80 |
| 2025-03-28 | -4.87 |
| 2025-03-27 | -4.85 |
| 2025-03-26 | -4.81 |
| 2025-03-25 | -4.91 |
| 2025-03-24 | -5.26 |
| 2025-03-21 | -5.55 |
| 2025-03-20 | -5.50 |
| 2025-03-19 | -5.55 |
| 2025-03-18 | -5.69 |
| 2025-03-17 | -5.56 |
| 2025-03-14 | -5.37 |
| 2025-03-13 | -5.03 |
| 2025-03-12 | -5.22 |
| 2025-03-11 | -5.21 |
| 2025-03-10 | -5.15 |
| 2025-03-07 | -5.34 |
| 2025-03-06 | -5.31 |
| 2025-03-05 | -5.85 |
| 2025-03-04 | -6.19 |
| 2025-03-03 | -5.92 |
| 2025-02-28 | -6.15 |
| 2025-02-27 | -6.15 |
| 2025-02-26 | -6.58 |
| 2025-02-25 | -6.20 |
| 2025-02-24 | -6.37 |
| 2025-02-21 | -6.40 |
| 2025-02-20 | -6.27 |
| 2025-02-19 | -4.74 |
| 2025-02-18 | -4.99 |
| 2025-02-14 | -4.97 |
| 2025-02-13 | -5.27 |
| 2025-02-12 | -5.00 |
| 2025-02-11 | -4.87 |
| 2025-02-10 | -4.77 |
| 2025-02-07 | -4.73 |
| 2025-02-06 | -4.59 |